IMMUNITY, PROPHYLAXIS AND VACCINES
- The starting line for COVID-19 vaccine.
Minor forms develop neutralizing antibodies - Hydroxychloroquine – time flies
- Pros and cons to HCQ
- Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells
- Targets of T Cell Responses to SARS-CoV-2
- Maskadom initiative – do they work?
- Cloth masks
WHO NOSE?
EPIDEMIOLOGY
- The estimated impact of the COVID-19 epidemic in the general population of France
- Super-spreaders
- Exposed children often escape infection
- Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak
- Schools reopen for children with chronic diseases
- The benefits of randomness, Einstein’s two mistakes
KEEP CALM AND CARRY ON…
RENAL
- Controversies of renin–angiotensin system inhibition
- Management of patients with immune-mediated kidney disease
- Presentation and Outcomes of Patients with ESKD and COVID-19
- SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
- The COVID rheumatology alliance
- Kidney involvement in COVID-19 and rationale for extracorporeal therapies
- Minimizing the risk of COVID-19 among patients on dialysis
- Beyond COVID-19, Low Serum Bicarbonate and CKD Progression in Children.
- Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in mouse and human kidneys
INTERNATIONAL
RENAL
MISCELLANEOUS
In today’s ZIP file COVID 30 mai 2020 interesting papers.
Published on Linkedin<https://www.linkedin.com/pulse/covid-snp-30-mai-michel-tsimaratos>
All docs and letters available on-line<https://www.snephroped.org/covid/>
Best regards.
Merci à Florentine Garaix, Philippe Hugot, Martin Christian, Eric Thervet, Alexandre Fabre, Stephane Burtey, Rob Ross Russell, Pierre Cochat, Labros Stefas, Nathalie Quiles et Lucas Percheron.
Michel Tsimaratos
Mis à jour le 30 mai 2020